Loading clinical trials...
Loading clinical trials...
Double-blind, Placebo-controlled, Clinical Trial on Efficacy and Safety of 12-months Therapy With Inhaled Colistimethate Sodium in the Treatment of Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa
Conditions
Interventions
CMS
Placebo
Locations
85
Australia
Zambon Investigative Site
Adelaide, Australia
Zambon Investigative Site
Adelaide, Australia
Zambon Investigative Site
Chermside, Australia
Zambon Investigative Site
Concord, Australia
Zambon Investigative Site
Frankston, Australia
Zambon Investigative Site
Greenslopes, Australia
Start Date
June 6, 2017
Primary Completion Date
April 9, 2021
Completion Date
April 9, 2021
Last Updated
November 15, 2023
Lead Sponsor
Zambon SpA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions